Human recombinant a-Synuclein, biotin labeled – 200 µg

Overview

Introducing our Human recombinant a-Synuclein, biotin labeled – 200 µg, an essential tool for researchers investigating Parkinson’s disease (PD). This protein plays a pivotal role in neurodegeneration and is integral to understanding the mechanisms behind dopaminergic neuron loss in the substantia nigra. With our high-quality biotin-labeled a-Synuclein, you can advance your studies in neuropathology and the molecular pathways involved in PD.

Key Features

• Biotin labeled for easy detection and labeling
• Recombinant form of human a-Synuclein (1-140)
• Purity exceeding 95%, ensuring reliable experimental results
• Produced in a controlled environment, minimizing contamination risks
• Ideal for use in assays focused on neurodegenerative diseases

Specifications

FAQ

What is a-Synuclein?

a-Synuclein is a protein associated with synaptic function in neurons and is known for its role in the development of Parkinson’s disease through its aggregation.

How is this product used in research?

This biotin-labeled a-Synuclein can be used in various assays, including immunoassays and binding studies, making it a valuable reagent in studying PD and related neurodegenerative conditions.

Is this protein suitable for in vitro studies?

Yes, our Human recombinant a-Synuclein is purified for in vitro applications, ensuring that you can trust the integrity and reliability of your experimental results.

Enhance your research with our Human recombinant a-Synuclein, biotin labeled – 200 µg. This protein is not just a reagent; it’s an essential component for your studies into Parkinson’s disease etiology. Explore our full range of recombinant proteins and assay kits to complement your research, including options like Recombinant mouse MOG (1-125) and Recombinant human MOG (1-125). Don’t miss the opportunity to advance your work with our high-quality products.

Related Products

• EndoClear™ Plus human recombinant a-Synuclein protein

Browse more in Catalog recombinant.